Sawai Group Holdings Co., Ltd. (TYO:4887)
1,960.50
+11.00 (0.56%)
Aug 1, 2025, 3:30 PM JST
Sawai Group Holdings Revenue
In the fiscal year ending March 31, 2025, Sawai Group Holdings had annual revenue of 189.02B JPY with 6.88% growth. Sawai Group Holdings had revenue of 45.82B in the quarter ending March 31, 2025, with 12.28% growth.
Revenue
189.02B
Revenue Growth
+6.88%
P/S Ratio
1.20
Revenue / Employee
57.11M
Employees
3,310
Market Cap
226.34B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 189.02B | 12.16B | 6.88% |
Mar 31, 2024 | 176.86B | -23.48B | -11.72% |
Mar 31, 2023 | 200.34B | 6.53B | 3.37% |
Mar 31, 2022 | 193.82B | 6.60B | 3.52% |
Mar 31, 2021 | 187.22B | 4.68B | 2.56% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.22B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 866.03B |
Takeda Pharmaceutical Company | 4,480.25B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,036.17B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |